Mario Occhipinti

14PUBLICATIONS

88CO-AUTHORS

Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Context learningMolecular targetsCancer diagnosisPredictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (14)

Sort by Publication Date:

|Jun 04, 2026

Alectinib and gastrointestinal perforation in ALK-rearranged non-small cell lung cancer: A case series.

|Nov 24, 2025

Combining Clinician Expertise with Prompt Engineering enhances Small Language Models Reliability for Cancer Entity Recognition in Electronic Health Records.

Federica Corso, Vittoria Peppoloni, Laura Mazzeo

|Nov 14, 2025

Actionable Genomic Alterations in Large Cell Neuroendocrine Carcinoma: A European Case Series of Patients Treated With a Small Molecule Inhibitor.

Frank W J Heijboer, Marta Brambilla, Mario Occhipinti

|Jul 16, 2025

Breast cancer and large-cell neuroendocrine carcinoma harboring the same <i>PIK3CA</i> mutation: A case report.

Emma Zattarin, Teresa Beninato, Giorgia Di Liberti

|Nov 08, 2024

Emerging Radiopharmaceuticals in Pet Imaging for Mesothelioma: A Review of [<sup>18</sup>F]FDG Alternatives.

Priscilla Guglielmo, Cinzia Crivellaro, Angelo Castello

|Apr 16, 2024

Response to lorlatinib rechallenge in a case of ALK-rearranged metastatic NSCLC with a resistance mutation to second generation TKIs.

Rita Leporati, Daniela Miliziano, Teresa Beninato

Pageof 3

Frequent Collaborators

Marta Brambilla

Laura Mazzeo

Teresa Beninato

Sara Manglaviti

Rita Leporati

Arsela Prelaj

Alessio Cortellini

Margherita Piccinelli

1 joint publications

Olga Nigro

1 joint publications

Michele De Tursi

Frequent Collaborators

Marta Brambilla

Laura Mazzeo

Teresa Beninato

Sara Manglaviti